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Objective. To examine the effect of severe pre-eclampsia
on maternal and cord erythrocyte membrane essential
fatty acid profiles.
Design. Clinical trial.
Setting. Obstetric High Care Unit, Tygerberg Hospital.
Patients. Erythrocyte membrane (EM) essential fatty acid
profiles were determined in 17 women with severe pre-
eclampsia, in 17 normotensive pregnant women, and in
the cord blood of their respective infants.
Results. Pre-eclamptic women had lower EM
phosphatidylcholine linoleic acid (C18:2n-6; LA) and a-
linolenic acid (C18:3n-3; ALA) levels and lower EM
phosphatidylethanolamine ALA levels than the
normotensive women with lower cord blood
docosahexaenoic acid levels (C22:6n-3; DHA) in both
phospholipid fractions. All cord blood arachidonic acid
(C20:4n-6; AA) levels were higher than the maternal levels.
Conclusions. Pre-eclamptic women have lower LA and
ALA levels than normotensive pregnant women, but AA
and DHA levels in the two groups are similar. The cord
blood DHA levels of infants of pre-eclamptic women are
lower than those of the infants of normotensive women.
Infants born to pre-eclamptic women may need dietary
DHA to replenish DHA stores. This can be obtained from
breast-milk or from a formula enriched with DHA.
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Essential fatty acid (EFA) metabolites are transported to fetal
tissues by erythrocytes, and their profiles in the erythrocyte
membrane (EM) reflect the adequacy of placental transport. 1
In the event of impaired placental function, as occurs in
severe pre-eclampsia, the maternal plasma and EM levels of
linoleic acid (C18:2n-6; LA) and a-linolenic acid (C18:3n-3;
ALA) are reduced. 2•3 The reason for this is not completely
understood. LA and ALA may be more rapidly metabolised
through an elongation and desaturation process to ensure
an adequate supply of their metabolites to the fetus."·
The EFAs LA and ALA are indispensable for optimal fetal
brain and retinal development.,,6 The fetus is unable to
synthesise these fatty acids and depends on maternal
intake.'·6 Although premature infants are capable of
biosynthesising docosahexaenoic acid (C22:6n-3; DHA) from
ALA, the amounts of DHA produced may be inadequate for
optimal neural development.' ALA in particular is essential
for optimal retinal and brain development because of its
long-chain polyunsaturated fatty acid metabolite, DHA,5,6,.
Selective biomagnification of metabolites from EFAs occurs
from the maternal to the fetal circulation, which favours
arachidonic acid (C20:4n-6; AA) and DHA,',6 This results in
high fetal levels of AA and DHA and low fetal levels of LA
and ALA compared with maternallevels.6,. This supply of
selected EFA metabolites (namely AA and DHA) to the fetus
is necessary for normal brain and retinal development.',',6,.
Transplacental passage of EFAs and their metabolites
occurs mainly during the third trimester."·" Infants born
prematurely have higher AA and DHA status when fed
human milk.'D Generally, preterm formulas and parenteral
lipid emulsions do not contain AA and DHA.
The objective of this study was to determine the impact of
severe pre-eclampsia on the maternal EM EFA and EFA
metabolite profiles of affected women and their infants at
birth.
Patients and methods
Seventeen infants of women of mixed racial descent with
severe pre-eclampsia who delivered before 34 weeks'
gestation were matched with infants of 17 normotensive
women, also of mixed racial descent and with onset of
labour before 34 weeks' gestation. The women were
approached regarding participation on admission to hospital
but were only included in the study if they delivered between
Monday and Friday, because blood samples could not be
processed over weekends. Dietary information was not
obtained from the women. The diagnosis of severe pre-
eclampsia was defined as follows: (I) maternal blood
pressure exceeding 180/120 mmHg on at least two
occasions at least 30 minutes apart with 2+ or more
proteinuria (Multistix; Ames) during the initial 24 hours after
admission; or (iI) a blood pressure of 160/110 - 180/120
mmHg on two occasions at least 6 hours apart with 2+ or
more proteinuria; or (iil) a blood pressure of 150/100 -
160/110 mmHg on two occasions at least 6 hours apart and
3+ or more proteinuria; or (iv) a blood pressure of 140/90
mmHg or more with proteinuria and clinical signs of
imminent eclampsia (epigastric pain, severe headache,
visual disturbances, nausea, brisk reflexes) before 34 weeks'
pregnancy duration."




The women with pre-eclampsia were monitored in the
Obstetric High Care Unit at Tygerberg Hospital until 34
weeks' gestation was reached unless maternal or fetal
indications necessitated earlier delivery.
At the time of delivery, 2 ml venous blood was obtained
from the mother and cord blood from the umbilical vein
immediately after clamping, and the blood was transferred
to a tube containing citrate as anticoagulant. Erythrocytes
were obtained by centrifugation and then resuspended in
2 ml saline (0.9% sodium chloride) and stored at -70°C for a
maximum of 2 weeks until analysis. EMs were prepared by
haemolysing erythrocytes with various phosphate buffers.'2,'3
Lipids were extracted from EMs with chloroform/methanol
(2:1 v/v), separated by thin-layer chromatography and
analysed for fatty acid composition of EM
phosphatidylcholine (PC) and phosphatidylethanolamine (PE)
by gas-liquid chromatography.,·,'5 A model 3700 Varian gas-
liquid chromatograph using fused silica megabore OB-225
columns (J & W Scientific, Cat. No. 125-2232) was used.
Gas flow rates were as follows: hydrogen (carrier gas), 5 - 8
ml/min; medical air, 250 ml/min; and hydrogen, 25 ml/min.
Temperature programming was linear at 3°C/min, initial
temperature was 165°C, final temperature was 220°C,
injection temperature was 240°C, and detector temperature
was 250°C. A fatty acid mixture standard was prepared from
individual fatty acids (Sigma, St Louis, Mo., USA). Fatty acid
methyl esters of PC and PE were identified by comparison
of the retention times with those of the standard mixture of
free fatty acids from 14:0 to 22:6w3. The PC fraction may
have included some phosphatidylinositol (PI) and
phosphatidylserine (PS), because of the close proximity of
these two fractions to PC after TLC separation. Gestational
age was calculated by using menstrual history, antenatal
ultrasound before 20 weeks' gestation or gestational
assessment according to the new Ballard score.'· Informed
consent was obtained from each woman on study entry. The
study was approved by the Ethics Committee of the Faculty
of Medicine of the University of Stellenbosch.
All values were expressed as the mean and standard
deviation (SO). Statistical differences of the clinical
characteristics and maternal and cord blood fatty acid levels
between the normotensive women and the women with pre-
eclampsia and their infants were determined using the
Wilcoxon two-sample test. The differences between the
maternal and cord blood EFA levels within each group (pre-
eclamptic and normotensive) were determined using the
Wilcoxon sign rank test for paired data. The x2-test was
used to determine any difference in the distribution of small-
for-gestational-age (SGA) infants between the normotensive
and pre-eclamptic groups.
Results
Maternal and infant characteristics are shown in Table I.
None of the clinical characteristics were significantly
different between the pre-eclamptic and the normotensive
women, or between their infants.
Table I. Maternal and infant characteristics (mean (SO))
Pre-eclampsia Normotensive Significance
(N =17) (N =17) (P-value)"
Maternal characteristics
Age (yrs) 29.3 (5.1) 28.3 (6.1) 0.6784
Gravidity 2.9 (1.8) 2.2 (0.9) 0.6786
Parity 1.5 (1.2) 1.1 (0.8) 0.4895
Infant characteristics
Birth weight (g) 1168.8 (236.2) 1450.9 (504.0) 0.0516
Gestation (wks) 29 7 (2.2) 30.9 (2.3) 0.1449
Small for gestational
age (%) 58.8 52.9 0.730
'Wilcoxon two-sample test.
Table 11 compares the EM PC fatty acid composition of the
women with pre-eclampsia and the cord blood of their
infants with those of the normotensive women and their
infants. LA and ALA levels were lower in the EMs of the
women with pre-eclampsia (P < 0.01). Their metabolic n-6
and n-3 end products were, however, not affected. This was
reflected by the higher (P < 0.05) indices of n-6 desaturation
Table 11. EM PC fatty acid composition (%) of pre-eclamptic and normotensive women and their respective cord bloods at delivery (mean
(SO»)
Maternal blood Cord blood Maternal v. cord
Pre-eclampsia Normotensive Pre-eclampsia Normotensive Pre-eclampsia Normotensive
(N =17) (N =17) (N =17) (N = 17) P-value P-value
n-6 fatty acids
LA 14.04" (1.68) 15.46' (1.49) 7.37 (2.74) 6.60 (1.51) 0.0001 0.0001
AA 10.41 (1.51 ) 9.99 (1.85) 16.12 (2.36) 16.28 (3.09) 0.0001 0.0001
I n-6 27.18 (2.03) 28.19 (2.04) 28.00 (2.81) 28.01 (4.44) 0.1594 0.8536
Index of n-6 desaturation" 0.95' (0.19) 0.83' (0.18) 3.01 (0.67) 3.38 (0.95) 0.0001 0.0001
n-3 fatty acids
ALA 0.68' (0.23) .09' (0.05) 0.54 (0.24) 0.80 (0.4S) 0.0315 0.0500
EPA 0.29 (0.22) 0.39 (0.39) 0.23 (0.26) 0.20 (0.24) 0.0942 0.0536
DPA 0.99 (0.43) 0.95 (0.49) 0.32 (0.37) 0.12 (0.23) 0.0002 0.0002
DHA 6.49 (1.62) 5.70 (1.29) 5.40 (1.35) 5.55 (1.77) 0.0038 0.5710
I n-3 8.45 (2.12) 8.13 (1.61) 6.49 (1.71) 6.67 (1.67) 0.0005 0.0395
Index of n-3 desaturation' 12.73' (5.21) 8.22' (5.03) 13.69 (7.20) 9.91 (5.44) 0.5791 0.3529
Significant diHerence (Wileaxon sign rank test for paired data): 'P < 0.05; 'P < O.Ol.
"L n-6/LA.
L n-3/ALA.
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(I n-6/LA) and n-3 desaturation (I n-3/ALA) in EMs of the
women with pre-eclampsia compared with the normotensive
women. LA levels were lower and AA levels higher (P =
0.0001) in the cord blood of all the infants compared with
the maternal levels. ALA (P < 0.05) and docosapentaenoic
acid (C22:5n-3; OPA; P = 0.0002) levels were lower in all the
infants compared with their maternal bloods. OHA levels
were lower only in the cord blood of infants born to the
women with pre-eclampsia (P =0.0038).
Table III compares the EM PE fatty acid composition of
the women with pre-eclampsia and the cord bloods of their
infants with that of the normotensive women and their
infants. Maternal ALA was the only fatty acid level that was
lower (P < 0.01) in the EMs of the women with pre-
eclampsia than in the EMs of the normotensive women. This
was reflected by the higher n-3 index (P < 0.05) of the EMs
of the women with pre-eclampsia. LA levels were lower and
AA levels higher (P = 0.0001) in the cord blood of all the
infants when the cord blood and maternal levels were
compared. This was also reflected by higher total n-6 fatty
acids and the higher n-6 indices. Compared with maternal
fatty acids, eicosapentaenoic acid (C20:5n-3; EPA) and OPA
levels were lower in the cord blood of all the infants (P =
0.0001). OHA levels were lower only in the cord blood of the
women with pre-eclampsia (P = 0.0079).
Discussion
This study showed that LA and ALA levels in women with
pre-eclampsia are lower than in normotensive pregnant
women.'" However, despite the lower levels of LA and ALA
in the pre-eclamptic women, the levels of their respective
metabolites, AA and OHA, are similar to those of
normotensive pregnant women. The findings in pre-
eclamptic women reported by AI et al.' and Wang et a/.' of
lower EPA and higher OHA levels, respectively, were not
confirmed by this study.
Conflicting EFA and EFA metabolite levels have been
reported for women with pre-eclampsia. Van der Schouw et
a/. 3 reported reduced plasma LA levels but normal ALA
levels in pre-eclamptic compared with normotensive
pregnant women, while Ogburn et al." and Williams et al."
noted increased plasma and EM AA levels, respectively, in
women with pre-eclampsia when compared with
normotensive controls.
The reasons for the reduced LA and ALA levels in women
with pre-eclampsia are unknown. Wang et a/.' suggested
that LA and ALA are metabolised more rapidly to their
metabolites as well as prostanoids and leukotrienes via the
cyclo-oxygenase/lipo-oxygenase pathways in pre-eclamptic
women. Van der Schouw et a/. 3 argue that a higher fetal
demand for n-6 EFA metabolites results in more active
elongation and desaturation processes during pre-eclampsia
to compensate for a less efficient placental transfer of the
n-6 EFA metabolites. The placental infarctions and
obliteration of tertiary villi associated with pre-eclampsia
may result in a decreased transfer of the EFA metabolites to
the fetus. >9.20 A shortcoming of this study was the
unavailability of a dietary history. Van Jaarsveld et al." found
low ALA levels in pregnant women with low-birth-weight
infants from a mixed racial background in the Western Cape.
The EM LA and AA levels found in women with pre-
eclampsia and normotensive women and in cord blood in
the present study are consistent with those previously
reported, viz. lower LA and higher AA levels in neonates.L'
We did not detect any difference in the AA levels in either
normotensive women or those with pre-eclampsia compared
with their infants. In both groups the AA levels in the cord
EMs were 1.5 times higher than the maternal levels. The n-6
PC desaturase index was, however, significantly higher in
the women with pre-eclampsia in the present study. This
supports the presence of a more active desaturase process
in these women, ensuring an adequate transfer of AA to
their fetuses.
In contrast to the high cord EM AA levels, the OHA levels
of infants of women with pre-eclampsia were significantly
lower than the OHA levels in their mothers, while no
significant reduction in EM OHA levels occurred in the
normotensive infants compared with those of their mothers.
Table Ill. EM PE fatty acid composition (%) of pre·eclamptic and normotensive women and their respective cord bloods at delivery
(mean (SO))
Maternal blood Cord blood Maternal v. cord
Pre-eclampsia Normotensive Pre-eclampsia Normotensive Pre-eclampsia Normotensive
(N = 17) (N = 17) (N = 17) (N = 17) P-value P-value
n-6 tatty acids
LA 6.37 (lAl) 6.98 (1.33) 3.37 (1.58) 2.97 (0.65) 0.0001 0.0001
AA 18.02 (2.14) 17Al (2.08) 25.25 (3.36) 25.83 (350) 0.0001 0.0001
Ln-6 29.78 (3A9) 29AO (2.99) 36.82 (4.54) 37.36 (4.82) 0.0001 0.0002
Index of n-6 desaturatlon' 3.87 (1.09) 3.33 (0.78) 11.05 (3.05) 12.09 (2.99) 0.000 0.000
n-3 fatty aCids
ALA 1.06' (0.47) 1.74' (0.80) 1.16 (0.78) 1.64 (1.12) 0.0926 0.7915
EPA '.16 (0.89) lA3 (0.80) OA, (OA4) 0.24 (0.31) 0.0001 0.0001
DPA 2.67 (1.05) 2.81 (1.05) 0.72 (0.92) 0.50 (0.67) 0.0001 0.0001
DHA 10.30 (2.62) 10.34 (2.07) 8.58 (2.01) 8.77 (2.33) 0.0079 00638
Ln-3 15.19 (3.98) 16.32 (3.02) 10.86 (2A9) , 1.15 (2.50) 00002 0.0005
Index of n-3 desatura Ion' 15.91- (7.25) 10.60' (6.24) 12A2 (8.06) 9.04 (5.99) 0.0638 0.6441
S;gn,'lcant cfere~ce llA coxon s go rank. .esl 'or pe. rea oala ~p < 005, :P < 0,0'
• ~ n-6sLA
-~ n-3ALA
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The significantly higher index of n-3 desaturation of the
women with pre-eclampsia compared with the normotensive
pregnant women supports the presence of a more active n-3
desaturation process in the presence of pre-eclampsia to
compensate for reduced placental transfer of OHA to the
fetus. Despite the increased production of DHA, as indicated
by the raised index of n-3 desaturation, the OHA levels in
cord blood of the infants of the women with pre-eclampsia
were significantly lower than the DHA levels in their mothers.
Felton et al." reported decreased DHA but normal AA
phospholipid umbilical vein wall levels in growth-retarded
small-far-gestational age infants compared with
appropriately grown infants; they considered that this was
probably due to an impaired placental supply of EFAs."
DHA is essential for the development and functioning of
the retina and central nervous system of the fetus and
neonate."·23 The rate of DHA accretion in the fetal brain and
retina is very high during the phase of rapid brain growth
that occurs from the 26th week of gestation until the first
few months after birth."'23 Preterm infants born during the
early third trimester of pregnancy are deprived of EFAs and
their metabolites. '.' EM DHA levels also reflect the availability
of OHA in neural tissue phospholipids with erythrocyte DHA
depletion preceding changes in brain DHA.'·" Infants born to
normotensive women before 32 weeks' gestation have lower
concentrations of PE DHA in brain, liver and erythrocytes
than do infants born at term.'''''' The infants born to women
with pre-eclampsia in the present study were delivered at a
mean of 29.7 weeks' gestation. Their low cord EM DHA
levels relative to the maternal EM DHA levels imply a
reduced EFA metabolite uptake over a period of 2 - 3
months compared with the normotensive infants. The high
prevalence of SGA infants in the normotensive group is
probably due to the inclusion of constitutionally small infants
in this group.
A diet rich in DHA during the first few months after birth
may provide for normal brain DHA accumulation in very-Iow-
birth-weight infants born to pre-eclamptic women."" This
can be achieved by feeding them breast-milk, which
contains both AA and DHA.' A high dietary intake of DHA in
the form of fish by lactating women increases the DHA
content of their breast-milk."'''' Preterm formulas are rich in
LA and ALA, but preterm infants have a limited ability to
transform these substrates into DHA and ALA.'" If a preterm
formula is used, it should be ascertained whether it is
enriched with DHA and AA. Currently, parenteral lipid
emulsions contain none of the EFA metabolites,
underscoring the importance of early enteral intake of DHA
and AA.31-32
Although preliminary findings on the prevention of severe
pre-eclampsia by supplementation with marine oil during
pregnancy need to be substantiated,"'" such
supplementation could possibly reduce the severity of pre-
eclampsia and simultaneously supply OHA to the developing
fetal brain and retina.' This supplementation could be
continued during lactation.
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